Chemotherapy Induced Neutropenia Completed Phase 2 Trials for Filgrastim (DB00099)

Also known as: Neutropenia post-chemotherapy / Chemotherapy-Induced Neutropenia / Chemotherapy Associated Neutropenia / Chemotherapy-induced neutropenia (disorder) / Neutropenia, unspecified / Neutropenia / Neutropenia (disorder) [Ambiguous] / Neutropenic disorder (disorder) / (Agranulocytosis) or (Kostmann's syndrome) or (neutropenia) / Neutropenias

IndicationStatusPhase
DBCOND0051348 (Chemotherapy Induced Neutropenia)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04345900Plinabulin vs. Pegfilgrastim in Patients With Solid Tumors Receiving Docetaxel Myelosuppressive Chemotherapy Phase 2Treatment
NCT01569087Dose-finding Study of Empegfilgrastim for Neutropenia Prophylaxis in Patients With Breast CancerSupportive Care
NCT01923545Phase II Study of DA-3031(PEG-G-CSF) in Chemotherapy-induced NeutropeniaTreatment